{"latest_checked": "2026-08-13T04:33:12.746470+00:00", "coverage_count": 5070, "recent_count": 12, "transaction_limit": 160, "filters": {"q": "", "ticker": "VCEL", "sector": "", "industry": "", "side": "", "start": "2026-06-29", "end": "2026-08-13"}, "summary": {"total": 12, "acquisition_count": 8, "disposal_count": 4, "acquisition_value": 308410.0, "acquisition_value_label": "$308.4K", "disposal_value": 688450.0, "disposal_value_label": "$688.5K", "net_value": -380040.0, "net_value_label": "$-380.0K", "flow_tone": "negative", "largest_value_label": "$468.4K", "top_sector": "Healthcare", "window_label": "29 Jun 2026 to 13 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 12, "value": "996860.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$996.9K"}], "days": [{"transaction_date": "2026-07-30", "acquisitions": 6, "disposals": 3, "total": 9, "bar_width": 100.0}, {"transaction_date": "2026-08-03", "acquisitions": 2, "disposals": 1, "total": 3, "bar_width": 33.3}], "side_mix": {"acquisitions": 8, "disposals": 4, "acquisition_share": 66.7, "disposal_share": 33.3}}, "company_flows": [{"symbol": "VCEL", "name": "Vericel Corp Ord", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-08-03", "acquisitions": 4, "disposals": 4, "acquired_value": 308410.0, "acquired_value_label": "$308.4K", "disposed_value": 688450.0, "disposed_value_label": "$688.5K", "net_value": -380040.0, "net_value_label": "$-380.0K", "acquisition_share": 50.0, "disposal_share": 50.0, "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}], "company_overview": [{"symbol": "VCEL", "name": "Vericel Corp Ord", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-08-03", "filings": 12, "acquisitions": 8, "disposals": 4, "acquired_value": 308410.0, "acquired_value_label": "$308.4K", "disposed_value": 688450.0, "disposed_value_label": "$688.5K", "net_value": -380040.0, "net_value_label": "$-380.0K", "acquisition_share": 66.7, "disposal_share": 33.3, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}], "transactions": [{"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-03", "executive": "HALPIN, MICHAEL", "executive_title": "Chief Operating Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:23:59.826238+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-03", "executive": "HALPIN, MICHAEL", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 46.84, "transaction_value": 468400.0, "transaction_value_label": "$468.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.828696+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-03", "executive": "HALPIN, MICHAEL", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 16.66, "transaction_value": 166600.0, "transaction_value_label": "$166.6K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.830707+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:23:59.832491+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:23:59.836080+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 2500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:23:59.834313+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2500.0, "share_price": 48.9, "transaction_value": 122250.0, "transaction_value_label": "$122.2K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.843084+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2500.0, "share_price": 29.82, "transaction_value": 74550.0, "transaction_value_label": "$74.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.841270+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 48.9, "transaction_value": 73350.0, "transaction_value_label": "$73.3K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.839457+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 34.9, "transaction_value": 52350.0, "transaction_value_label": "$52.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.837777+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 500.0, "share_price": 48.9, "transaction_value": 24450.0, "transaction_value_label": "$24.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.846636+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}, {"symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "SIEGAL, JONATHAN", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 500.0, "share_price": 29.82, "transaction_value": 14910.0, "transaction_value_label": "$14.9K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:23:59.844809+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vcel/", "research_links": {"chart": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/", "report": "/terminal/0c30525e-bb29-4e07-ada3-96c6e14349f7/report/", "factor": "/factors/ticker/0c30525e-bb29-4e07-ada3-96c6e14349f7/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}